GM19800
LCL from B-Lymphocyte
Description:
NEUROFIBROMATOSIS, TYPE II; NF2
NEUROFIBROMIN 2; NF2
Repository
|
NIGMS Human Genetic Cell Repository
|
Subcollection |
Heritable Diseases Hereditary Cancers |
Class |
Disorders of Uncertain Biochemical Etiology |
Biopsy Source
|
Peripheral vein
|
Cell Type
|
B-Lymphocyte
|
Tissue Type
|
Blood
|
Transformant
|
Epstein-Barr Virus
|
Sample Source
|
LCL from B-Lymphocyte
|
Relation to Proband
|
proband
|
Confirmation
|
Molecular characterization before cell line submission to CCR
|
Species
|
Homo sapiens
|
Common Name
|
Human
|
Remarks
|
|
IDENTIFICATION OF SPECIES OF ORIGIN |
Species of Origin Confirmed by Nucleoside Phosphorylase,Glucose-6-Phosphate Dehydrogenase, and Lactate Dehydrogenase Isoenzyme Electrophoresis |
|
Gene |
NF2 |
Chromosomal Location |
22q12.2 |
Allelic Variant 1 |
; NEUROFIBROMATOSIS, TYPE 2 |
Identified Mutation |
1539A>G |
Remarks |
Clinically affected; bilateral vestibular schwannomas; donor subject has an A>G transition at nucleotide 1539 in exon 14 of the NF2 gene [1539A>G]. |
Gene Cards |
NF2 |
Gene Ontology |
GO:0005198 structural molecule activity |
|
GO:0005856 cytoskeleton |
|
GO:0005886 plasma membrane |
|
GO:0007605 perception of sound |
|
GO:0008092 cytoskeletal protein binding |
|
GO:0008285 negative regulation of cell proliferation |
|
GO:0045786 negative regulation of cell cycle |
NCBI Gene |
Gene ID:4771 |
NCBI GTR |
101000 NEUROFIBROMATOSIS, TYPE II; NF2 |
|
607379 NEUROFIBROMIN 2; NF2 |
OMIM |
101000 NEUROFIBROMATOSIS, TYPE II; NF2 |
|
607379 NEUROFIBROMIN 2; NF2 |
Omim Description |
ACOUSTIC NEURINOMA, BILATERAL; ACNNEUROFIBROMIN 2, INCLUDED |
|
ACOUSTIC SCHWANNOMAS, BILATERAL |
|
BILATERAL ACOUSTIC NEUROFIBROMATOSIS; BANF |
|
MERLIN, INCLUDED |
|
NEUROFIBROMATOSIS, CENTRAL TYPE |
|
NEUROFIBROMATOSIS, TYPE II; NF2 |
|
SCHWANNOMIN, INCLUDED; SCH, INCLUDED |
Split Ratio |
1:4 |
Temperature |
37 C |
Percent CO2 |
5% |
Percent O2 |
AMBIENT |
Medium |
Roswell Park Memorial Institute Medium 1640 with 2mM L-glutamine or equivalent |
Serum |
15% fetal bovine serum Not Inactivated |
Substrate |
None specified |
Subcultivation Method |
dilution - add fresh medium |
Supplement |
- |
|
|